Related Experiment Video

Updated: Mar 9, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.0K

Mixed Results for Sunitinib in Renal Cancer

    Cancer Discovery
    |January 8, 2017
    PubMed

    Insights

    Sunitinib may prevent kidney cancer recurrence after surgery. Another study suggests cabozantinib is a more effective first-line treatment than sunitinib for metastatic renal cell carcinoma.

    Area of Science:

    • Oncology
    • Nephrology
    • Pharmacology

    Background:

    • Renal cell carcinoma (RCC) is a significant health concern.
    • Sunitinib is a tyrosine kinase inhibitor used in RCC treatment.
    • Adjuvant and first-line therapies for metastatic RCC are areas of active research.

    Framework:

    • Two studies presented at the European Society for Medical Oncology 2016 Congress informed this analysis.
    • Study 1 focused on adjuvant sunitinib post-nephrectomy.
    • Study 2 compared first-line cabozantinib versus sunitinib in metastatic RCC.

    Implementation:

    • Sunitinib demonstrated efficacy in preventing recurrence in patients following kidney cancer removal.
    • Cabozantinib showed superior efficacy compared to sunitinib as a first-line treatment for metastatic RCC.

    Implications:

    • Adjuvant sunitinib may improve outcomes for resected RCC patients.
    • Cabozantinib presents a promising alternative for first-line treatment of metastatic RCC, potentially improving patient survival and quality of life.

    More Related Videos

    A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

    A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

    Published on: April 12, 2017

    14.4K
    Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy11:27

    Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

    Published on: April 29, 2014

    17.3K

    Related Concept Videos

    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    4.9K
    Renal Drug Excretion: Tubular Reabsorption01:25

    Renal Drug Excretion: Tubular Reabsorption

    Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
    1000
    Renal Drug Excretion: Tubular Secretion01:28

    Renal Drug Excretion: Tubular Secretion

    Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
    1.0K
    Renal Drug Excretion: Overview01:15

    Renal Drug Excretion: Overview

    As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
    A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
    874
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    6.1K
    Renal Drug Clearance: Overview01:06

    Renal Drug Clearance: Overview

    Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
    Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
    917